Table 2.

Mean concentrations of biomarkers in serum and oral fluids at baseline visit.

		Ablation		PCI
		Mean	Std	Mean	Std
Adiponectin	S	24440.00	11599.38	24191.00	10279.57
	UWS	39.95	53.80	48.78	67.55
	GS	2.16	2.53	1.14	1.09
	LS	2.01	3.30	0.83	0.83
BNP	S	326.05*	308.28	84.32	92.78
	UWS	13.27	9.53	10.51	11.82
	GS	1.60	0.55	2.08	0.94
	LS	1.93	0.68	2.60	0.57
CK-MB	S	2.92	1.72	3.64	5.36
	UWS	0.29	0.31	0.53	0.85
	GS	0.04	0.07	0.00	0.00
	LS	0.00	0.00	0.00	0.00
CRP	S	35781.30	59021.73	26560.50	49873.73
	UWS	4.66	8.99	6.11	11.56
	GS	4.24	9.03	3.95	11.35
	LS	4.27†	9.20	0.03	0.04
IL-1β	S	87.20	328.46	127.29	394.49
	UWS	135.58	198.81	127.84	169.10
	GS	1.07	0.80	0.55	0.32
	LS	3.27	5.30	0.77	0.49
IL-6	S	76.67	129.71	48.14	122.38
	UWS	18.25	21.13	22.79	23.10
	GS	0.93	0.70	1.07	0.81
	LS	1.48	1.64	0.64	0.41
MMP-9	S	252215.70	396157.66	251010.90	307621.92
	UWS	9808.03	16904.29	7244.71	14883.90
	GS	5718.05	13583.66	7444.61	17473.19
	LS	14.58	13.92	16.59	13.56
MPO	S	149656.40	234395.66	165870.30	218208.36
	UWS	9590.41	11074.34	8184.74	9518.86
	GS	4870.39	9443.62	5990.67	9359.94
	LS	35.92	13.96	129.47	249.20
MYO	S	33.76	20.03	39.15	15.92
	UWS	1.12	0.91	1.35	0.70
	GS	0.48	0.23	0.43	0.10
	LS	0.50	0.14	0.65	0.07
sCD-40L	S	11082.10	7000.96	8550.90	2550.05
	UWS	10.89	10.33	10.89	9.89
	GS	2.96	2.61	3.35	3.16
	LS	5.33	3.50	3.77	3.04
sICAM-1	S	230.47	123.96	241.30	83.96
	UWS	1.75†	1.57	3.31	2.90
	GS	0.22	0.12	0.31	0.18
	LS	0.20	0.18	0.29	0.20
TNFα	S	53.65	109.45	37.26	90.96
	UWS	9.58	15.42	6.81	4.55
	GS	1.20	1.59	0.99	0.89
	LS	2.04	4.15	0.81	0.68
TnI	S	0.04	0.07	0.16	0.43
	UWS	0.02	0.01	0.02	0.02
	GS	0.01	0.01	0.01	0.01
	LS	0.00	0.00	0.01	0.01

ng/mL: TnI, CK-MB, MYO, CRP, Adiponectin, MMP-9, MPO, sICAM-1

pg/mL: BNP, IL-1β, IL-6, TNFα, sCD40-L

^*indicates significantly different from mean analyte value of PCI group (p <0.01)

^†indicates significantly different from mean value of PCI group (p<0.05). Both determined by two sample t-test.